Cleared Special

K233553 - MiniSpacer 1024

K233553 is an FDA 510(k) clearance for MiniSpacer 1024, manufactured by Thayer Medical Corporation. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Special 510(k) pathway after a 225-day FDA review.

K233553 · Thayer Medical Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2024
Decision
225d
Days
Class 2
Risk

K233553 is an FDA 510(k) clearance for the MiniSpacer® 1024, 1025, 1543 and 1024A, 1025A, 1543A Dual Spray MDI Adapter. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Thayer Medical Corporation (Tucson, US). The FDA issued a Cleared decision on June 18, 2024 after a review of 225 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Thayer Medical Corporation devices

FDA 510(k) Submission Details - K233553

510(k) Number K233553 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2023
Decision Date June 18, 2024
Days to Decision 225 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
85d slower than avg
Panel avg: 140d · This submission: 225d
Pathway characteristics
Modification to existing cleared device.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Pathmaker FDA Law, PLLC
Amy Fowler

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 196
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K233553.
HeroTracker Sense
K250022 · Voluntis · Jun 2025
AdheResp Smart Breath-actuated Mesh Nebulizer
K250583 · Hcmed Innovations Co., Ltd. · Jun 2025
AllNEB
K242354 · Enchant Tek Co. , Ltd. · Apr 2025
Aerogen®Solo Nebulizer System
K232507 · Aerogen, Ltd. · May 2024
Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%
K232523 · Mankind Pharma Limited · Apr 2024
Hudson RCI® AddiPak® Unit Dose Vial
K231058 · Medline Industries, LP · Jan 2024